Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate
(26)
- Computing and Computational Sciences Directorate (38)
- Energy Science and Technology Directorate (223)
- Fusion and Fission Energy and Science Directorate (24)
- Isotope Science and Enrichment Directorate (7)
- National Security Sciences Directorate (20)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (135)
- User Facilities (27)
- (-) Information Technology Services Directorate (3)
Researcher
- Andrzej Nycz
- Chris Masuo
- Luke Meyer
- William Carter
- Alex Walters
- Annetta Burger
- Brian Sanders
- Bruce Hannan
- Carter Christopher
- Chance C Brown
- Debraj De
- Gautam Malviya Thakur
- Gerald Tuskan
- Ilenne Del Valle Kessra
- Isaiah Dishner
- James Gaboardi
- Jason Jarnagin
- Jeff Foster
- Jerry Parks
- Jesse McGaha
- John F Cahill
- Josh Michener
- Joshua Vaughan
- Kevin Spakes
- Kevin Sparks
- Liangyu Qian
- Lilian V Swann
- Liz McBride
- Loren L Funk
- Mark Provo II
- Paul Abraham
- Peter Wang
- Polad Shikhaliev
- Rob Root
- Sam Hollifield
- Theodore Visscher
- Todd Thomas
- Vilmos Kertesz
- Vladislav N Sedov
- Xiaohan Yang
- Xiuling Nie
- Yacouba Diawara
- Yang Liu

Often there are major challenges in developing diverse and complex human mobility metrics systematically and quickly.

Enzymes for synthesis of sequenced oligoamide triads and tetrads that can be polymerized into sequenced copolyamides.
Contact
To learn more about this technology, email partnerships@ornl.gov or call 865-574-1051.

The ever-changing cellular communication landscape makes it difficult to identify, map, and localize commercial and private cellular base stations (PCBS).

ORNL has developed a large area thermal neutron detector based on 6LiF/ZnS(Ag) scintillator coupled with wavelength shifting fibers. The detector uses resistive charge divider-based position encoding.

Detection of gene expression in plants is critical for understanding the molecular basis of plant physiology and plant responses to drought, stress, climate change, microbes, insects and other factors.

Direct-acting antivirals are needed to combat coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).

There is a critical need for new antiviral drugs for treating infections of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).